| scholarly article | Q13442814 |
| P50 | author | Beate K Straub | Q45373493 |
| P2093 | author name string | Judith Lehmann-Koch | |
| Michael Boutros | |||
| Wilfried Roth | |||
| Christina Falschlehner | |||
| Dorothee Nickles | |||
| Marie Metzig | |||
| P2860 | cites work | Deubiquitylating enzymes and disease | Q21284381 |
| Towards a proteome-scale map of the human protein–protein interaction network | Q21735930 | ||
| The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2 | Q24296502 | ||
| BLOC1S2 interacts with the HIPPI protein and sensitizes NCH89 glioblastoma cells to apoptosis | Q24306314 | ||
| Suppression of cancer cell growth by promoting cyclin D1 degradation | Q24317660 | ||
| Secretion of Wnt ligands requires Evi, a conserved transmembrane protein | Q24329123 | ||
| Stress-induced decrease in TRAF2 stability is mediated by Siah2 | Q24539054 | ||
| Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls | Q24570128 | ||
| CellProfiler: image analysis software for identifying and quantifying cell phenotypes | Q24676898 | ||
| Immunity, Inflammation, and Cancer | Q27861048 | ||
| Tumor necrosis factor receptor-associated factors (TRAFs) | Q28199382 | ||
| Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB | Q28201706 | ||
| The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer | Q28253300 | ||
| Regulation and function of IKK and IKK-related kinases | Q28268930 | ||
| A genomic and functional inventory of deubiquitinating enzymes | Q28284911 | ||
| Good cop, bad cop: the different faces of NF-kappaB | Q28291669 | ||
| Shared principles in NF-kappaB signaling | Q29547234 | ||
| Activators and target genes of Rel/NF-kappaB transcription factors | Q29547882 | ||
| An RNA interference screen identifies Inhibitor of Apoptosis Protein 2 as a regulator of innate immune signalling in Drosophila. | Q33223553 | ||
| Cellular phenotyping by RNAi. | Q33246559 | ||
| Signal transduction by tumor necrosis factor and its relatives | Q34341941 | ||
| NF-kappaB and breast cancer | Q34995649 | ||
| NF-kappaB: tumor promoter or suppressor? | Q35753163 | ||
| The novel functions of ubiquitination in signaling | Q35804780 | ||
| NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis | Q35971557 | ||
| A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions | Q36011021 | ||
| A pervasive role of ubiquitin conjugation in activation and termination of IkappaB kinase pathways | Q36089051 | ||
| Ubiquitylation and cell signaling | Q36251951 | ||
| NF-kappaB and cancer: mechanisms and targets | Q36468005 | ||
| TNFalpha blockade in human diseases: mechanisms and future directions | Q36536886 | ||
| Deubiquitinating enzymes as novel anticancer targets | Q36536984 | ||
| Exploiting our knowledge of NF-kappaB signaling for the treatment of mammary cancer | Q36561723 | ||
| Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression | Q36637905 | ||
| Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation | Q37028019 | ||
| Ubiquitin-mediated regulation of TNFR1 signaling | Q37178522 | ||
| Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer | Q37376029 | ||
| Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival | Q39761203 | ||
| The isopeptidase USP2a protects human prostate cancer from apoptosis | Q40236434 | ||
| Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. | Q40400391 | ||
| Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases | Q40573595 | ||
| Caspase-mediated cleavage, IAP binding, and ubiquitination: linking three mechanisms crucial for Drosophila NF-kappaB signaling | Q42920131 | ||
| Mass spectrometric analysis of tumor necrosis factor receptor-associated factor 1 ubiquitination mediated by cellular inhibitor of apoptosis 2. | Q45092993 | ||
| Down-regulation of the de-ubiquitinating enzyme ubiquitin-specific protease 2 contributes to tumor necrosis factor-alpha-induced hepatocyte survival | Q46253089 | ||
| The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma | Q46866555 | ||
| Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma | Q58619568 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | NF-κB | Q411114 |
| TNF | Q18032037 | ||
| P304 | page(s) | 607-618 | |
| P577 | publication date | 2011-08-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | An RNAi screen identifies USP2 as a factor required for TNF-α-induced NF-κB signaling | |
| P478 | volume | 129 |
| Q42039947 | A genome-wide RNA interference screen identifies caspase 4 as a factor required for tumor necrosis factor alpha signaling. |
| Q41864059 | A genome-wide siRNA screen reveals positive and negative regulators of the NOD2 and NF-κB signaling pathways. |
| Q38931043 | BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence |
| Q38200936 | Circadian clocks and inflammation: reciprocal regulation and shared mediators |
| Q35955141 | Deubiquitinases in cancer |
| Q37945451 | Deubiquitinases in cancer: new functions and therapeutic options. |
| Q94475913 | Downregulation of ubiquitin-specific protease 2 possesses prognostic and diagnostic value and promotes the clear cell renal cell carcinoma progression |
| Q35210773 | Effects of sleep deprivation and aging on long-term and remote memory in mice |
| Q35034170 | Epigenetic changes associated with inflammation in breast cancer patients treated with chemotherapy |
| Q38907126 | Epigenetic silencing of miR-708 enhances NF-κB signaling in chronic lymphocytic leukemia |
| Q34115693 | Identification of F-box only protein 7 as a negative regulator of NF-kappaB signalling. |
| Q35207348 | Identifying USPs regulating immune signals in Drosophila: USP2 deubiquitinates Imd and promotes its degradation by interacting with the proteasome |
| Q35971438 | K63-linked ubiquitination in kinase activation and cancer |
| Q37427080 | Microarray analysis provides new insights into the function of apolipoprotein O in HepG2 cell line |
| Q35814459 | Peroxisomal Import Reduces the Proapoptotic Activity of Deubiquitinating Enzyme USP2 |
| Q37995682 | Regulation of NF-κB by deubiquitinases |
| Q34398961 | Systematic analysis of the physiological importance of deubiquitinating enzymes |
| Q39116600 | The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways. |
| Q64924690 | The Many Roles of Ubiquitin in NF-κB Signaling. |
| Q35986574 | The emerging role of proteolysis in mitochondrial quality control and the etiology of Parkinson's disease |
| Q36284134 | The pineal gland: A model for adrenergic modulation of ubiquitin ligases |
| Q37400805 | The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation |
| Q36001939 | Transcriptome signature of resistance exercise adaptations: mixed muscle and fiber type specific profiles in young and old adults |
| Q39345375 | USP2a negatively regulates IL-1β- and virus-induced NF-κB activation by deubiquitinating TRAF6. |
| Q42771733 | USP2a positively regulates TCR-induced NF-κB activation by bridging MALT1-TRAF6. |
| Q36126977 | USP2a protein deubiquitinates and stabilizes the circadian protein CRY1 in response to inflammatory signals |
| Q43375902 | Ubiquitin-Specific Protease 2 Modulates the Lipopolysaccharide-Elicited Expression of Proinflammatory Cytokines in Macrophage-like HL-60 Cells. |
| Q38835722 | Ubiquitin-specific peptidase 2 as a potential link between microRNA-125b and psoriasis |
| Q35049396 | Ubiquitin-specific proteases 25 negatively regulates virus-induced type I interferon signaling |
Search more.